ANIK Q2 2021 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$38M+24.3% YoY

Gross Profit

$21M54.6% margin

Operating Income

$9M24.1% margin

Net Income

$7M17.1% margin

EPS (Diluted)

$0.45

QoQ Revenue Growth

+11.2%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$363M

Total Liabilities

$76M

Stockholders' Equity

$287M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$31M	+24.3%
Gross Profit	$21M	$14M	+51.4%
Operating Income	$9M	-$10M	+196.3%
Net Income	$7M	-$8M	+184.7%

Revenue Segments

Product

$38M50%

Joint Pain Management Therapies

$24M32%

Joint Preservation and Restoration

$12M16%

Manufactured Product, Other

$2M3%

Geographic Segments

UNITED STATES

$30M86%

Europe

$5M14%